Dia-M
Generic Name
dia-m-500-mg-tablet
Manufacturer
Example Pharmaceutical Co. Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
Variant | Unit Price | Strip Price |
---|---|---|
dia m 500 mg tablet | ৳ 1.10 | N/A |
Description
Overview of the medicine
Dia-M 500 mg Tablet contains Metformin Hydrochloride, an oral antidiabetic medication used to manage type 2 diabetes mellitus. It helps to lower blood glucose levels by decreasing glucose production in the liver, decreasing intestinal absorption of glucose, and improving insulin sensitivity.
Uses & Indications
Dosage
Adults
Initial dose is typically 500 mg once or twice daily with meals. May be gradually increased to a maximum of 2000-2550 mg/day in divided doses. Extended-release formulations may be taken once daily.
Elderly
Elderly patients should be started on conservative doses, and renal function should be closely monitored due to increased risk of lactic acidosis.
Renal_impairment
Contraindicated in severe renal impairment (eGFR < 30 mL/min/1.73 m²). Dose adjustment required for eGFR 30-60 mL/min/1.73 m² (e.g., maximum 1000 mg/day).
How to Take
Take orally with food to reduce gastrointestinal side effects. Swallow the tablet whole; do not crush or chew.
Mechanism of Action
Metformin primarily acts by decreasing hepatic glucose production (gluconeogenesis) and increasing insulin sensitivity in peripheral tissues (skeletal muscle and adipose tissue), leading to increased glucose uptake and utilization. It also reduces glucose absorption from the gastrointestinal tract.
Pharmacokinetics
Onset
Within hours of administration, full effect seen over several days to weeks.
Excretion
Renal excretion, predominantly by active tubular secretion.
Half life
Plasma elimination half-life is approximately 6.2 hours.
Absorption
Absolute bioavailability is 50-60%. Food decreases the extent and slightly delays the absorption of Metformin.
Metabolism
Metformin is excreted unchanged in the urine; it does not undergo hepatic metabolism (no CYP450 involvement) nor biliary excretion.
Side Effects
Contraindications
- Hypersensitivity to Metformin or any component of the formulation.
- Severe renal impairment (eGFR < 30 mL/min/1.73 m²).
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.
- Acute myocardial infarction, septicemia, or other conditions associated with hypoxemia.
- Severe hepatic impairment.
Drug Interactions
Alcohol
Increases the risk of lactic acidosis.
Cimetidine
Increases Metformin plasma concentration.
Iodinated contrast agents
Risk of lactic acidosis; temporarily discontinue Metformin before or at the time of the procedure and for 48 hours after.
Diuretics (e.g., Thiazides)
May reduce the renal clearance of Metformin or increase blood glucose levels.
Storage
Store in a cool, dry place, below 30°C. Protect from light and moisture. Keep out of reach of children.
Overdose
Overdose of Metformin primarily leads to lactic acidosis. Treatment involves supportive measures, correction of acidosis, and hemodialysis for severe cases to remove Metformin and lactate.
Pregnancy & Lactation
Pregnancy: Limited data suggest Metformin may be used to manage gestational diabetes or type 2 diabetes during pregnancy if benefits outweigh risks, under strict medical supervision. Lactation: Metformin is excreted into breast milk. Monitor infants for adverse effects. Consult a physician.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
24 to 36 months from the date of manufacture
Availability
Available in pharmacies nationwide
Approval Status
Approved by relevant regulatory authorities
Patent Status
Off-patent
WHO Essential Medicine
YesClinical Trials
Metformin has undergone extensive clinical trials demonstrating its efficacy and safety in managing type 2 diabetes. Ongoing research continues to explore its potential benefits in other conditions.
Lab Monitoring
- Renal function (eGFR) should be assessed before initiating Metformin and at least annually thereafter. More frequent monitoring is required for elderly patients or those with risk factors for renal impairment.
- Hematologic parameters (e.g., Vitamin B12 levels) should be monitored periodically, especially in patients with anemia or risk factors for B12 deficiency.
Doctor Notes
- Before prescribing, assess renal function (eGFR) and continue monitoring annually or more frequently as clinically indicated.
- Advise patients on the symptoms of lactic acidosis and to seek immediate medical attention if they occur.
- Consider vitamin B12 supplementation or monitoring in patients on long-term Metformin therapy, especially those with neuropathy or anemia.
Patient Guidelines
- Take Metformin regularly as prescribed by your doctor.
- Always take Metformin with food to minimize gastrointestinal side effects.
- Inform your doctor if you experience symptoms of lactic acidosis (e.g., unusual muscle pain, difficulty breathing, unusual stomach discomfort, dizziness).
- Do not stop taking Metformin without consulting your doctor.
Missed Dose Advice
If you miss a dose, take it as soon as you remember with food, unless it is almost time for your next dose. In that case, skip the missed dose and resume your usual dosing schedule. Do not double the dose.
Driving Precautions
Metformin monotherapy does not typically cause hypoglycemia, so it is unlikely to affect your ability to drive or operate machinery. However, if used in combination with other antidiabetic agents that can cause hypoglycemia, or if you experience dizziness, caution is advised.
Lifestyle Advice
- Maintain a balanced diet and regular exercise routine as advised by your healthcare provider.
- Monitor your blood glucose levels regularly as instructed.
- Avoid excessive alcohol consumption.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
Related
Medicines
Explore similar medicines to find the best option for your healthcare needs.
Exalin
Square Pharmaceuticals Ltd.
Evoloxin
Incepta Pharmaceuticals Ltd.
Avilam
Various (e.g., Sanofi as Avil)
Azilpres
Specific manufacturer varies by region (e.g., Square Pharmaceuticals Ltd. in BD for a generic Azilsartan product)
Axxo
Square Pharmaceuticals Ltd.
Exler
Incepta Pharmaceuticals
EuroORS
Euro Pharma Ltd.
Exib
Incepta Pharmaceuticals Ltd.
Exomi MUPS
Square Pharmaceuticals Ltd.
Avloquin-H
General Pharmaceuticals Ltd.